Use of self-efficacy and dyspnea perceptions to predict functional performance in people with COPD.

This correlational and comparative study explored whether self-reports of self-efficacy and dyspnea perceptions predict the perceived level of functional performance in adults who have chronic obstructive pulmonary disease (COPD). The convenience sample included 97 Caucasian men (52) and women (45). Participants had to have a forced expiratory volume in 1 second (FEV1) of less than 70% predicted, and a FEV1/forced vital capacity (FVC) of less than 70%. Participants were recruited from pulmonary function laboratories and from better breather support groups in a Midwestern state. Three standardized, self-report instruments, COPD Self-Efficacy Scale (CSES), the Pulmonary Functional Status and Dyspnea Questionnaire (PFSDQ), and Functional Performance Inventory (FPI) were used to measure the participants' self-report of their perceptions of self-efficacy, dyspnea, and functional performance. Dyspnea predicted 38.1% of the variance in functional performance, with self-efficacy contributing an additional 6.5% to the variance in the total sample. Self-efficacy predicted 36.5% of the variance in functional performance in men, with dyspnea contributing an additional 7.2% to the variance. However, in women, only dyspnea was a significant predictor of functional performance, at 48.5% when both dyspnea and self-efficacy were entered as independent variables. To improve patients' perceptions of functional performance, nurses can use methods such as breathing techniques and upper- and lower-body exercises that increase optimal management of dyspnea. Nurses may increase the self-efficacy of managing dyspnea by helping patients master breathing techniques and exercise through coaching and providing vicarious experiences through patient support groups or pulmonary rehabilitation programs.     

急性脑出血患者血清谷氨酸动态变化分析

目的通过观察脑出血（intracerebral hemorrhage，ICH）患者血清中谷氨酸的动态变化来进一步评价谷氨酸对脑出血的作用。方法选择符合条件的30例急性高血压脑实质出血患者，给予神经内科脑出血常规治疗，采用高效液相色谱法检测起病后2d内、5．6d、8-9d和15．16d的血清谷氨酸浓度，同步进行神经功能评定，同时于发病后1．3d、d5-6d及d15．16行头部CT检查了解血肿体积大小。结果脑出血患者血中谷氨酸浓度与血肿体积及神经功能缺损评分之间呈正的直线相关。经治疗后，所有病例谷氨酸水平迅速下降，在5-6d和8—9d下降速度更加明显。结论谷氨酸可能参与了自发性脑出血患者的急性期脑损伤作用。     

计算机自动定量诊断脑萎缩的初步研究

目的研究正常人群脑容积随年龄及性别的变化规律,提出计算机定量诊断脑萎缩的客观标准。方法利用最新提出的脑容积计算机自动定量算法,测量了脑萎缩组487例(男,310例,女,177例)和正常组1901例(男,993例,女,908例)的颅腔容积、脑容积和脑实质分数(BPF),并通过多项式曲线拟合技术,研究正常人BPF随年龄变化的函数关系。结果正常组颅腔容积为(1271322±128699)mm3,脑容积为(1211725±122077)mm3,BPF为(95.3471±2.3453)%;脑萎缩组颅腔容积为(1276900±125180)mm3,脑容积为(1203400±117760)mm3,BPF为(91.8115±2.3035)%。两组之间的颅腔容积和脑容积差异无统计学意义(P>0.05),而BPF差异具有统计学意义(P<0.001);BPF定量与年龄之间的二次多项式函数关系P(x)=-0.0008x2+0.0193x+96.9999能够较为准确表达正常人BPF随年龄变化的函数关系,其95%可信区间下限为y=-0.0008x2+0.0184x+95.1090。结论BPF与年龄之间函数关系的95%可信区间下限,可作为计算机自动定量诊断脑萎缩的客观标准。     

计算机辅助带锁髓内钉固定胫骨骨折全程规划手术系统的实验研究

目的评价计算机辅助带锁髓内钉固定胫骨骨折全程手术规划系统的有效性及临床可行性。方法在分析系统结构和操作流程的基础上,利用塑料胫骨模型(9根)和尸体胫骨(12具下肢肢体)进行基于C型臂透视图像的术中骨折肢体图像拼接、骨折闭合复位及髓内钉置入仿真测量实验；利用胫骨模型及尸体胫骨进行图像拼接精度分析,以验证图像拼接与规划模块的正确性。利用尸体胫骨进行计算机辅助骨折闭合复位试验,分析骨折复位机构模块的操作可行性。结果图像拼接模块只需术中采集7～10张有效的C型臂图像即可拼接出下肢长骨的全景图像,为采集图像所需的术中透视时间为(19．75±0．61)s；计算机进行X线透视图像采集和拼接总时间为(4．17±0．86)min；塑料模型拼接精度达(1．26±0．76)mm。结论该系统实现了基于C型臂拼接图像的计算机辅助胫骨骨折髓内钉内固定全程手术规划,术中可完成骨折复位图像分析、手术规划、虚拟仿真,髓内钉型号选择以及骨折复位等关键操作,为计算机辅助骨科手术系统治疗长骨骨折搭建了精确、安全、稳定的软硬件技术平台。     

活性金属单环165的临床研究

不锈钢环型节育器(金单环)在中国广为应用。为提高金单环的避孕效果,进行了金单环支撑力与脱落关系的研究,对200,165,135g不同支撑力进行比较性研究筛选出较为合理的支撑力为165g,其外形和金单环相似,分大、中、小三种型号,大号外径22mm,中号21mm,小号为20mm。外层为不锈钢丝螺旋簧,在螺旋环内相间置入纯铜丝(200mm2)和消炎痛硅橡胶各二段(消炎痛总含量5mg左右,现已改为10mg)。于1988年10月～1989年6月全国南北方7省市11所医院共放置1000例,经3年定期随访,12,24,36个月继续存放率各为92.5,88.99及85.94/100妇女年,36月累积带器妊娠率仅1.61/100妇女,脱落率比原金单环明显降低近40％,因症取出率为3.12。于放置前后进行月经血量测量24例,放置后3、6月各增加24.4％和27.4％。行子宫内膜“含铜含药组”和“有铜无药”组对照检查各11例,含药组炎症细胞略少。作宫颈粘液中铜离子含量测定,以6月内含量较高,6月后趋向平稳。消炎痛释放测定,1月内释放较快,一年后残留20％左右。经1249例临床观察,活性金单环165是一种不需特殊培训易于推广的、安全、经济并能长期放置的IUD。     

PHA RMA COKINETICS OF CUPRIC－BIS（SALICYLALDEHYDE－2－FURA NTHIOCA RBOXY－HYDRAZONATE） DICHLORIDE（CSFTCH） IN RABBITS

ＰＨＡＲＭＡＣＯＫＩＮＥＴＩＣＳＯＦＣＵＰＲＩＣ－ＢＩＳ（ＳＡＬＩＣＹＬＡＬＤＥＨＹＤＥ－２－ＦＵＲＡＮＴＨＩＯＣＡＲＢＯＸＹ－ＨＹＤＲＡＺＯＮＡＴＥ）ＤＩＣＨＬＯＲＩＤＥ（ＣＳＦＴＣＨ）ＩＮＲＡＢＢＩＴＳ￥ＧａｏＹｕｎｓｈｅｎｇ；ＺｈｕＹｕｙｕｎ（...     

下肢静脉病变顺、逆行造影的诊断价值

目的:探讨下肢静脉病变顺、逆行造影X线表现与病理改变的关系。方法:回顾性分析86例(119侧)下肢静脉病变顺、逆行造影X线表现。结果:顺行造影显示原发性下肢深静脉瓣膜关闭不全84侧,交通静脉瓣膜关闭不全14侧,单纯性瓣膜关闭不全11侧,静脉瘤或弥漫性血管湖6侧,先天性下肢静脉发育异常4侧。逆行造影显示0级13侧,Ⅰ级58侧,Ⅱ级21侧,Ⅲ级19侧,Ⅳ级8侧。结论:下肢静脉病变顺、逆行同时造影能更好地显示下肢浅、深静脉瓣膜功能,为临床诊断或治疗提供非常有价值的依据。     

主动脉夹层血肿36例的诊治分析

目的　探讨主动脉夹层血肿的临床特点及诊治方法。方法　回顾性分析 3 6例主动脉夹层血肿的临床资料 ,分析其临床特点、误诊情况、影像学诊断及内科治疗。结果　 86.1%的病例有高血压史和现症高血压 ,其中合并冠心病 7例、糖尿病 4例、高脂血症 17例 ;88.9的病例有胸、腰背或腹痛并呈游走性 ;经治疗病情缓解出院 2 8例 ,占 77.8% ;死亡 8例 ,病死率为 2 2 .2 %。结论　结合临床表现和影像学检查 ,发现内膜撕裂口、钙化的内膜内移或真假腔 ,是确诊主动脉夹层血肿的关键     

Combined treatment with a 5HT1A receptor agonist and a muscarinic acetylcholine receptor antagonist disrupts water maze navigation behavior

The present study was designed to investigate the effects of combined treatment with a serotonin (5-HT)_1A receptor agonist, 8-hydroxy-2-(dipropylamino)-tetralin (8-OH-DPAT), and a muscarinic acetylcholine receptor antagonist, scopolamine, on water maze (WM) navigation. Treatment with either 8-OH-DPAT or scopolamine before daily behavioral training disrupted spatial navigation at medium doses and cue navigation at high doses. Pretraining treatment with a combination of subthreshold doses of 8-OH-DPAT and scopolamine impaired WM spatial and cue navigation, but did not impair the WM performance if the drugs were injected post-training. In trained rats, combined injections of subthreshold doses of 8-OH-DPAT and scopolamine given pretraining did not impair the rats' ability to find the platform in a familiar or in a novel position. The combination of 8-OH-DPAT and scopolamine also disrupted WM navigation in rats with central 5-HT depletion. A combination of a peripheral muscarinic acetylcholine receptor antagonist and 8-OH-DPAT had no effect on WM navigation. These data suggest that combined treatment with drugs blocking muscarinic acetylcholine receptors and activating 5-HT_1A receptors greatly impairs WM learning/performance, but does not impair spatial memory per se.     

SRTR Center-Specific Reporting Tools: Posttransplant Outcomes

Measuring and monitoring performance—be it waiting list and posttransplant outcomes by a transplant center, or organ donation success by an organ procurement organization and its partnering hospitals—is an important component of ensuring good care for people with end-stage organ failure. Many parties have an interest in examining these outcomes, from patients and their families to payers such as insurance companies or the Centers for Medicare and Medicaid Services; from primary caregivers providing patient counseling to government agencies charged with protecting patients.
The Scientific Registry of Transplant Recipients produces regular, public reports on the performance of transplant centers and organ procurement organizations. This article explains the statistical tools used to prepare these reports, with a focus on graft survival and patient survival rates of transplant centers—especially the methods used to fairly and usefully compare outcomes of centers that serve different populations. The article concludes with a practical application of these statistics—their use in screening transplant center performance to identify centers that may need remedial action by the OPTN/UNOS Membership and Professional Standards Committee.